化学
可穿戴计算机
普鲁士蓝
糖尿病
恒电位仪
连续血糖监测
可穿戴技术
血糖自我监测
葡萄糖氧化酶
纳米技术
生物医学工程
生物传感器
材料科学
电极
内分泌学
电化学
1型糖尿病
嵌入式系统
计算机科学
物理化学
医学
作者
Nadtinan Promphet,Chusak Thanawattano,Chatchai Buekban,Thidarut Laochai,Panlop Lormaneenopparat,Wiwittawin Sukmas,Pranee Rattanawaleedirojn,Pumidech Puthongkham,Pranut Potiyaraj,Worapong Leewattanakit,Nadnudda Rodthongkum
标识
DOI:10.1016/j.aca.2024.342761
摘要
Diabetes is a significant health threat, with its prevalence and burden increasing worldwide indicating its challenge for global healthcare management. To decrease the disease severity, the diabetic patients are recommended to regularly check their blood glucose levels. The conventional finger-pricking test possesses some drawbacks, including painfulness and infection risk. Nowadays, smartphone has become a part of our lives offering an important benefit in self-health monitoring. Thus, non-invasive wearable sweat glucose sensor connected with a smartphone readout is of interest for real-time glucose detection. Wearable sweat glucose sensing device is fabricated for self-monitoring of diabetes. This device is designed as a body strap consisting of a sensing strip and a portable potentiostat connected with a smartphone readout via Bluetooth. The sensing strip is modified by carbon nanotubes (CNTs)-cellulose nanofibers (CNFs), followed by electrodeposition of Prussian blue. To preserve the activity of glucose oxidase (GOx) immobilized on the modified sensing strip, chitosan is coated on the top layer of the electrode strip. Herein, machine learning is implemented to correlate between the electrochemical results and the nanomaterial content along with deposition cycle of prussian blue, which provide the highest current response signal. The optimized regression models provide an insight, establishing a robust framework for design of high-performance glucose sensor. This wearable glucose sensing device connected with a smartphone readout offers a user-friendly platform for real-time sweat glucose monitoring. This device provides a linear range of 0.1 – 1.5 mM with a detection limit of 0.1 mM that is sufficient enough for distinguishing between normal and diabetes patient with a cut-off level of 0.3 mM. This platform might be an alternative tool for improving health management for diabetes patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI